Hemophilia in Canada

Both hemophilia A and B are very rare disorders.

Hemophilia A (Factor VIII) affects fewer than 1 in 10,000 people, or about 2,500 Canadians. Hemophilia B (Factor IV) is even less common, affecting about 1 in 50,000 people, or about 600 Canadians.

As of May 2010, 2625 people with Factor VIII deficiency, and 631 people with Factor IX deficiency were registered with the Canadian Hemophilia Registry.

Canadians with hemophilia get treatment and services from 1 of 24 Canadian hemophilia clinics located across Canada. Through shared membership with the Association of Hemophilia Clinic Directors of Canada (AHCDC), clinics operate with the help of the Canadian Hemophilia Society, Hema-Québec, and the Canadian Blood Services (CBS).

Canadian doctors and researchers are among the leaders in international hemophilia research, working to improve the lives of people with hemophilia.

Canadian Dr. David Lillicrap was the recipient of the prestigious ISTH Investigator Recognition Award, one of just five such awards issued at the XXI ISTH Congress of the International Society on Thrombosis and Haemostasis held in Geneva, Switzerland, in July of 2007.